Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00MZD
|
||||
| Former ID |
DNC003449
|
||||
| Drug Name |
7n-Methyl-8-Hydroguanosine-5'-Diphosphate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551393] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H19N5O11P2
|
||||
| Canonical SMILES |
CN1CN(C2=C1C(=O)N=C(N2)N)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)<br />O)O)O
|
||||
| InChI |
1S/C11H19N5O11P2/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(26-10)2-25-29(23,24)27-28(20,21)22/h4,6-7,10,17-18H,2-3H2,1H3,(H,23,24)(H2,20,21,22)(H3,12,13,14,19)/t4-,6-,7-,10-/m1/s1
|
||||
| InChIKey |
QQODJOAVWUWVHJ-KQYNXXCUSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | mRNA of Eukaryotic translation initiation factor 4E | Target Info | Inhibitor | [551393] | |
| PANTHER Pathway | p38 MAPK pathway | ||||
| CCKR signaling map ST | |||||
| PathWhiz Pathway | Leucine Stimulation on Insulin Signaling | ||||
| WikiPathways | Interferon type I signaling pathways | ||||
| Hypertrophy Model | |||||
| Insulin Signaling | |||||
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | |||||
| ISG15 antiviral mechanism | |||||
| Deadenylation-dependent mRNA decay | |||||
| Structural Pathway of Interleukin 1 (IL-1) | |||||
| BDNF signaling pathway | |||||
| Leptin signaling pathway | |||||
| miR-targeted genes in muscle cell - TarBase | |||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| Signaling by Insulin receptor | |||||
| Processing of Capped Intron-Containing Pre-mRNA | |||||
| Eukaryotic Translation Initiation | |||||
| Translation Factors | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.